138 related articles for article (PubMed ID: 25860636)
1. Retrospective Evaluation of Milrinone Pharmacokinetics in Children With Kidney Injury.
Gist KM; Mizuno T; Goldstein SL; Vinks A
Ther Drug Monit; 2015 Dec; 37(6):792-6. PubMed ID: 25860636
[TBL] [Abstract][Full Text] [Related]
2. Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery.
Mizuno T; Gist KM; Gao Z; Wempe MF; Alten J; Cooper DS; Goldstein SL; Vinks AA
Clin Pharmacokinet; 2019 Jun; 58(6):793-803. PubMed ID: 30607889
[TBL] [Abstract][Full Text] [Related]
3. Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review.
Gist KM; Goldstein SL; Joy MS; Vinks AA
J Cardiovasc Pharmacol; 2016 Feb; 67(2):175-81. PubMed ID: 26448275
[TBL] [Abstract][Full Text] [Related]
4. Time-Varying Clearance in Milrinone Pharmacokinetics from Premature Neonates to Adolescents.
O'Hanlon CJ; Sumpter A; Anderson BJ; Hannam JA
Clin Pharmacokinet; 2024 May; 63(5):695-706. PubMed ID: 38613610
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents.
Hornik CP; Yogev R; Mourani PM; Watt KM; Sullivan JE; Atz AM; Speicher D; Al-Uzri A; Adu-Darko M; Payne EH; Gelber CE; Lin S; Harper B; Melloni C; Cohen-Wolkowiez M; Gonzalez D;
J Clin Pharmacol; 2019 Dec; 59(12):1606-1619. PubMed ID: 31317556
[TBL] [Abstract][Full Text] [Related]
6. Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac Surgery.
Gist KM; Cooper DS; Wrona J; Faubel S; Altmann C; Gao Z; Marino BS; Alten J; Hock KM; Mizuno T; Vinks AA; Joy MS; Wempe MF; Bennett MR; Goldstein SL
Ther Drug Monit; 2018 Apr; 40(2):186-194. PubMed ID: 29529007
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.
Vogt W
Clin Pharmacokinet; 2014 Jan; 53(1):51-72. PubMed ID: 23839530
[TBL] [Abstract][Full Text] [Related]
8. Who may not benefit from continuous renal replacement therapy in acute kidney injury?
Kawarazaki H; Uchino S; Tokuhira N; Ohnuma T; Namba Y; Katayama S; Toki N; Takeda K; Yasuda H; Izawa J; Uji M; Nagata I;
Hemodial Int; 2013 Oct; 17(4):624-32. PubMed ID: 23651363
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
[TBL] [Abstract][Full Text] [Related]
10. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
[TBL] [Abstract][Full Text] [Related]
11. [Influence of time of initiation of continuous renal replacement therapy on prognosis of critically ill patients with acute kidney injury].
Hu ZJ; Liu LX; Zhao CC
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):415-9. PubMed ID: 23834940
[TBL] [Abstract][Full Text] [Related]
12. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
13. Continuous renal replacement therapy for critically ill infants and children.
Pedersen O; Jepsen SB; Toft P
Dan Med J; 2012 Feb; 59(2):A4385. PubMed ID: 22293054
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the systems for the identification of postoperative acute kidney injury in pediatric cardiac patients.
Lex DJ; Tóth R; Cserép Z; Alexander SI; Breuer T; Sápi E; Szatmári A; Székely E; Gál J; Székely A
Ann Thorac Surg; 2014 Jan; 97(1):202-10. PubMed ID: 24206964
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants.
Paradisis M; Jiang X; McLachlan AJ; Evans N; Kluckow M; Osborn D
Arch Dis Child Fetal Neonatal Ed; 2007 May; 92(3):F204-9. PubMed ID: 16690639
[TBL] [Abstract][Full Text] [Related]
16. Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation.
Riley AA; Watson M; Smith C; Guffey D; Minard CG; Currier H; Akcan Arikan A
BMC Nephrol; 2018 Oct; 19(1):268. PubMed ID: 30340544
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of milrinone for low systemic blood flow in very preterm infants.
Paradisis M; Evans N; Kluckow M; Osborn D; McLachlan AJ
J Pediatr; 2006 Mar; 148(3):306-13. PubMed ID: 16615956
[TBL] [Abstract][Full Text] [Related]
18. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction.
Cox ZL; Calcutt MW; Morrison TB; Akers WS; Davis MB; Lenihan DJ
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):433-8. PubMed ID: 23695773
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with acute kidney injury or failure in children undergoing cardiopulmonary bypass: a case-controlled study.
Chiravuri SD; Riegger LQ; Christensen R; Butler RR; Malviya S; Tait AR; Voepel-Lewis T
Paediatr Anaesth; 2011 Aug; 21(8):880-6. PubMed ID: 21306475
[TBL] [Abstract][Full Text] [Related]
20. Timing of continuous renal replacement therapy and mortality in critically ill children*.
Modem V; Thompson M; Gollhofer D; Dhar AV; Quigley R
Crit Care Med; 2014 Apr; 42(4):943-53. PubMed ID: 24231758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
